High-pressure-promoted Fmoc-aminoacylation of N-ethylcysteine: preparation of key devices for the solid-phase synthesis of peptide thioesters

Tetrahedron Letters

Volumn 51, Issue 2, 2010, Pages 407-410

  Nakahara, Yuko ^a,b   Matsuo, Ichiro ^b,c   Ito, Yukishige ^b   Ubagai, Risa ^a   Hojo, Hironobu ^a   Nakahara, Yoshiaki ^a  

^a TOKAI UNIVERSITY   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYL GROUP; CYSTEINE; CYSTEINE DERIVATIVE; DICHLOROMETHANE; ESTER DERIVATIVE; FLUORENYLMETHYLOXYCARBONYL CHLORIDE; FLUORENYLMETHYLOXYCARBONYL CHLORIDE AMINOACYL FLUORIDE; FLUORENYLMETHYLOXYCARBONYL CHLORIDE LEVO LEUCINE; FLUORIDE; LEUCINE; N ETHYL TRIPHENYLMETHYLCYSTEINE ALLYL ESTER; N ETHYLCYSTEINE; PEPTIDE THIOESTER; RESIN; THIOESTER; UNCLASSIFIED DRUG;

ALLYLATION; AMINOACYLATION; ARTICLE; CHEMICAL REACTION; CHIRALITY; CONTROLLED STUDY; DEPROTECTION REACTION; DIASTEREOISOMER; EPIMERIZATION; POLYMERIZATION; SOLID PHASE SYNTHESIS; STEREOCHEMISTRY; STEREOISOMERISM;

EID: 71049135695     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2009.11.034     Document Type: Article

References (39)

1. Hojo H., and Aimoto S. Bull. Chem. Soc. Jpn. 64 (1991) 111-117
2. Aimoto S. Biopolymer (Pept. Sci.) 51 (1999) 247-265
3. Dawson P.E., Muir T.W., Clark-Lewis I., and Kent S.B.H. Science 266 (1994) 776-779
4. Dawson P.E., and Kent S.B.H. Ann. Rev. Biochem. 69 (2000) 923-960
5. Futaki S., Sogawa K., Maruyama J., Asahara T., Niwa M., and Hojo H. Tetrahedron Lett. 38 (1997) 6237-6240
6. Li X., Kawakami T., and Aimoto S. Tetrahedron Lett. 39 (1998) 8669-8672
7. Shin Y., Winans K.A., Backes B.J., Kent S.B.H., Ellman J.A., and Bertozzi C.R. J. Am. Chem. Soc. 121 (1999) 11684-11689
8. Ingenito R., Bianchi E., Fattori D., and Pessi A. J. Am. Chem. Soc. 121 (1999) 11369-11374
9. Alsina J., Yokumu T.S., and Barany G. J. Org. Chem. 64 (1999) 8761-8769
10. Clippingdale A.B., Barrow C.J., and Wade J.D. J. Pept. Sci. 6 (2000) 225-234
11. Swinnen D., and Hilvert D. Org. Lett. 2 (2000) 2439-2442
12. Mezo A.R., Cheng R.P., and Imperiali B. J. Am. Chem. Soc. 123 (2001) 3885-3891
13. Ishii A., Hojo H., Nakahara Y., Ito Y., and Nakahara Y. Biosci., Biotechnol., Biochem. 66 (2002) 225-232
14. Brask J., Albericio F., and Jensen K. Org. Lett. 5 (2003) 2951-2953
15. Cararero J.A., Hackel B.J., de Yoreo J.J., and Mitchell A.R. J. Org. Chem. 69 (2004) 4145-4151
16. Warren J.D., Miller A.R., Keding S.J., and Danishefsky S.J. J. Am. Chem. Soc. 126 (2004) 6576-6578
17. Botti P., Villain M., Manganiello S., and Gaertner H. Org. Lett. 6 (2004) 4861-4864
18. Kawakami T., Sumida M., Nakamura K., Vorherr T., and Aimoto S. Tetrahedron Lett. 46 (2005) 8805-8807
19. Ollivier N., Behr J.-B., El-Mahdi O., Blanpain A., and Melnyk O. Org. Lett. 7 (2005) 2647-2650
20. Ohta Y., Itoh S., Shigenaga A., Shintaku S., Fujii N., and Otaka A. Org. Lett. 8 (2006) 467-470
21. Nagaike F., Onuma Y., Kanazawa C., Hojo H., Ueki A., Nakahara Y., and Nakahara Y. Org. Lett. 8 (2006) 4465-4468
22. Manabe S., Sugioka T., and Ito Y. Tetrahedron Lett. 48 (2007) 849-853
23. Kawakami T., and Aimoto S. Tetrahedron Lett. 48 (2007) 1903-1905
24. Ficht S., Payne R.J., Guy R.T., and Wong C.-H. Chem. Eur. J. 14 (2008) 3620-3629
25. Lelièvre D., Barta P., Aucagne V., and Delmas A.F. Tetrahedron Lett. 49 (2008) 4016-4019
26. Kang J., Richardson J.P., and Macmillan D. Chem. Commun. (2009) 407-409
27. Tsuda S., Shigenaga A., Bando K., and Otaka A. Org. Lett. 11 (2009) 823-826
28. Kawakami T., and Aimoto S. Tetrahedron 65 (2009) 3871-3877
29. Tofteng A.P., Sørensen K.K., Conde-Frieboes K.W., Hoeg-Jensen T., and Jensen K.J. Angew. Chem., Int. Ed. 48 (2009) 7411-7414
30. Hojo H., Onuma Y., Akimoto Y., Nakahara Y., and Nakahara Y. Tetrahedron Lett. 48 (2007) 25-28 2007, 48, 1299
31. King D.S., Fields C.G., and Fields G.B. Int. J. Pept. Protein Res. 36 (1990) 255-266
32. You S.-L., and Kelly J.W. J. Org. Chem. 68 (2003) 9506-9509 Commercial Fmoc-S-triphenylmethyl-cysteine was esterified with allyl alcohol, HOBt(N-hydroxybenzotriazole), HBTU [2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluroniumhexafluorophosphate]and DIEA, and N-deprotected to S-triphenylmethyl-cysteine allyl ester
33. Carpino L.A., Ionescu D., El-Faham A., Henklein P., Wenschuh H., Bienert M., and Beyermann M. Tetrahedron Lett. 39 (1998) 241-244
34. Brown Z.Z., and Schafmeister C.E. J. Am. Chem. Soc. 130 (2008) 14382-14383 and references cited therein
35. Matsuo I., Wada M., and Ito Y. Tetrahedron Lett. 43 (2002) 3273-3275
36. 1/n. The 3D drawing is shown in the online Supplementary data.
37. 2 was ultimately produced in a substantial quantity (8%).
38. D value was in fair agreement with that (+35.2) of the major dipeptide separately synthesized by high-pressure coupling of 4 and d-(Et)Cys(Trt)-OAll which was analogously prepared from Fmoc-d-Cys(Trt)-OH and allyl alcohol with HOBt, HBTU, and DIEA (see Ref. 6).
39. Wang S.-S., Gisin B.F., Winter D.P., Makofske R., Kulesha I.D., Tzougraki C., and Meienhofer J. J. Org. Chem. 42 (1977) 1286-1290